EP
ASMB icon

Eversept Partners’s Assembly Biosciences ASMB Stock Holding History

Eversept Partners’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Sell
40,889
-118,787
-74% -$3.39M 0.06% 103
2025
Q4 		$5.43M Buy
+159,676
New +$5.14M 0.27% 68
2022
Q2 		– Sell
-23,333
Closed -$577K – 80
2022
Q1 		$577K Sell
23,333
-2,500
-10% -$53.7K 0.04% 72
2021
Q4 		$722K Sell
25,833
-3,334
-11% -$109K 0.05% 94
2021
Q3 		$1.22M Buy
+29,167
New +$1.22M 0.08% 91

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Eversept Partners's ASMB Position: Q1 2026 in Review

Eversept Partners reduced its Assembly Biosciences (ASMB) stake by 74% in Q1 2026, selling an estimated $3.39M and leaving 40,889 shares worth $1.13M. The position accounts for 0.06% of the portfolio, ranked #103.

Eversept Partners first reported a position in ASMB in Q3 2021 and has held it in 5 quarters since. The position peaked at $5.43M in Q4 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Eversept Partners held 40,889 shares of Assembly Biosciences worth $1.13M as of Q1 2026.
  • Eversept Partners sold 118,787 Assembly Biosciences shares in Q1 2026, an estimated $3.39M.
  • Assembly Biosciences made up 0.06% of Eversept Partners's portfolio in Q1 2026, its #103 holding.
  • Eversept Partners first reported a position in Assembly Biosciences in Q3 2021 and has held it in 5 quarters since.
  • Eversept Partners's Assembly Biosciences position peaked at $5.43M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.